News Release: Research , School of Medicine , Winship Cancer Institute

Nov. 19,  2009

Regenerative Medicine Expert Jacques Galipeau, MD, Joins Emory

News Article ImageJacques Galipeau, MD

Jacques Galipeau, MD, has joined Emory University and the Winship Cancer Institute as visiting professor in hematology and medical oncology and visiting professor in Emory's Department of Pediatrics. Galipeau joins Emory from McGill University in Montreal.

A Georgia Cancer Coalition Distinguished Scholar, Galipeau is a world-renowned expert in cell and gene therapy of cancer and immune ailments and will also serve as deputy director of the Georgia Tech-Emory Center for Regenerative Medicine (GTEC). In addition, his goal is to establish a new cell therapy facility that will conduct "first-in-human" clinical studies of innovative new therapies.

"Dr. Galipeau's work has advanced the field of immune response and opened the door to important research in cell based therapies for cancer, arthritis and lupus," David Stephens, MD, vice president for research, Emory Woodruff Health Sciences Center, says. "His appointment here at Emory further strengthens our reputation for translational research excellence and enhances our ability to contribute to the emerging field of regenerative medicine."

Fadlo Khuri, MD, chair of the Department of Hematology and Medical Oncology, says, "We are delighted to have Dr. Galipeau join our team. Dr. Galipeau brings an exceptional track record of research innovation as demonstrated by his authorship of 15 publications in high-impact journals in 2009 alone. He has a well-earned reputation as a brilliant and caring physician, one whose entire research portfolio is targeted to improving patient care across a wide spectrum of diseases."

Most recently, Galipeau led a multidisciplinary team of researchers in developing a breakthrough experimental treatment that put multiple sclerosis into remission in mice by suppressing the immune system. The work was published in the September 2009 issue of Nature Medicine.

The treatment, named GIFT15, puts MS into remission by suppressing the immune response. GIFT15 is composed of two proteins, GSM-CSF and interleukin-15, fused together artificially in the lab. Under normal circumstances, the individual proteins act to stimulate the immune system, but in their fused form, the equation reverses itself. In addition, unlike earlier immune-suppressing therapies which rely on chemical pharmaceuticals, this approach is a personalized form of cellular therapy which utilizes the body's own cells to suppress immunity.

"Dr. Galipeau's work in enzyme replacement therapy is widely cited and has the potential for great impact in pediatric medicine," says Barbara Stoll, MD, chair of the Emory University School of Medicine Department of Pediatrics. "Emory and all of Georgia will benefit from Dr. Galipeau's presence here."

Galipeau has more than 90 publications in peer-reviewed scientific journals and is a Diplomat of the American Board of Internal Medicine, a Fellow of the Royal College of Physicians of Canada, and was a commissioned officer in the Canadian Armed Forces with Honorable Discharge at the rank of Infantry Captain. After earning his medical degree at the University of Montreal, Faculty of Medicine, Galipeau conducted a fellowship in hematology-oncology at Tufts University in Boston and a post doctoral fellowship in gene therapy at St. Jude Children's Research Hospital in Memphis.

Edmund Waller, MD, PhD, director of Winship's Bone Marrow and Stem Cell Transplant Center, says, "Dr. Galipeau is a visionary translational scientist. He will bring Emory and Georgia to the next level in immune response cancer research and in the delivery of effective cell therapy for cancer patients as well as other diseases such as multiple sclerosis." 

###

The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service.

Learn more about Emory’s health sciences:
Blog: http://emoryhealthblog.com
Twitter: @emoryhealthsci
Web: http://emoryhealthsciences.org

News Release Tools

  • Print

Related Resources

News Releases

The news release you are currently viewing is part of an archive of Emory health sciences press releases, dating Sept. 2008 - Dec. 2011.



To View Current Releases


Emory News Center

Emory News Center



To View News Archives


News Archives

News Archives